STAR Market Margin Balance Falls to RMB 348.2 Billion, Down for Third Day

As of September 11, 2026, the STAR Market's combined margin financing and securities lending balance stood at RMB 348.200 billion, down RMB 2.526 billion from the previous trading day and lower for three consecutive trading days. Margin financing totaled RMB 346.416 billion, a decrease of RMB 2.467 billion from the previous trading day, while securities lending totaled RMB 1.784 billion, down RMB 58.2656 million. The STAR Market's combined balance was RMB 350.726 billion on September 10, 2026; RMB 351.560 billion on September 9; RMB 351.932 billion on September 8; RMB 351.623 billion on September 7; and RMB 349.173 billion on September 4.

As of September 11, 2026, Cambricon had the highest margin financing balance on the STAR Market at RMB 17.642 billion. Montage Technology and SMIC had margin financing balances of RMB 14.421 billion and RMB 10.861 billion, respectively. Margin financing balances rose for 215 STAR Market stocks and fell for 388. The largest increases were at Gongda Gaoke, Guoyi Company, and Heda Technology, up 19.96%, 9.25%, and 8.11%, respectively. The largest declines were at Yingfang Software, Biocytogen, and Anjiesi, down 18.77%, 14.35%, and 13.77%, respectively. C Enflame listed on the STAR Market on September 11, 2026, and its margin financing balance on its first trading day was RMB 731.5807 million.

As of September 11, 2026, Cambricon had the highest securities lending balance on the STAR Market at RMB 87 million. Yuanjie Technology and SMIC had securities lending balances of RMB 66 million and RMB 53 million, respectively. Securities lending balances rose for 138 STAR Market stocks and fell for 284. The largest increases were at Aojing Medical, Kemei Diagnostics, and Shengnuo Biotech, up 2,852.22%, 73.94%, and 73.26%, respectively. The largest declines were at Aladdin, Juyi Technology, and Uni-Trend, down 84.54%, 81.35%, and 76.72%, respectively.